Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Head & Neck 1Genitourinary 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 1Parkinson Disease 1Glioma 1

Interventions

Temozolomide 20Magnetic Resonance Spectroscopy 10Radiotherapy 9Blood Specimen Collection 8pembrolizumab 6Cyclophosphamide 6Bevacizumab 6AZD 6244 6Radiation 5Specimen Handling 4fludarabine 3cemiplimab 3aflutinib 3Surgical Procedures, Operative 3Saline Solution 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Pemetrexed 3Granulocyte-Macrophage Colony-Stimulating Factor 3vorasidenib 2tislelizumab 2osimertinib 2naxitamab 2gallium maltolate 2fludarabine phosphate 2dinutuximab 2Topotecan 2Standard of Care 2Spinal Puncture 2Receptors, Interleukin-8B 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Positron Emission Tomography Computed Tomography × CNS × Clear all
NCT06914427 2025-04-06

PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique

Xijing Hospital

Phase NA Not yet recruiting
35 enrolled
CNSGenitourinary

Glioma, Parkinson Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡